Compare FirstEnergy Corp. (FE) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FirstEnergy Corp. vs Medpace Holdings Inc — how do they compare? FirstEnergy Corp. trades at $46.91 (market cap $27.10B), while Medpace Holdings Inc trades at $600.79 (market cap $16.90B). The key difference: FirstEnergy Corp. is the larger of the two by market cap, and FirstEnergy Corp. pays a 3.97% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| FE | MEDP | |
|---|---|---|
Market Cap | $27.10B | $16.90B |
Sector | Utilities | Technology |
52-Week High | $51.91 | $620.59 |
52-Week Low | $42.83 | $393.42 |
Enterprise Value | $56.02B | $16.52B |
Dividend Yield | 3.97% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FirstEnergy (FE) trades at $46.81, showing minimal daily movement (+0.11%). The stock faces bearish technical signals with mixed earnings performance, missing Q4 2025 and Q2 2026 EPS estimates but beating Q1 2026. Revenue growth is steady, reaching $15.09B in 2025, with a net income margin of 6.86%. Recent news highlights institutional buying and strong Q2 2026 results driven by data center demand.
Outlook: FE benefits from rising electricity demand and a $36B grid investment plan, supporting long-term growth. Risks include high debt levels and regulatory pressures. Analysts are cautiously optimistic with a $52.67 price target (12% upside), but technical weakness suggests near-term consolidation.
MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.
Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FirstEnergy Corp.
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
